LIVE WebinarWednesday, November 17, 20213:00 – 4:30 PM Eastern TimeRegister NowIn a growing number of individuals who contract COVID-19, symptoms continue long after the preliminary SARS-CoV-2 infection subsides. COVID-19 and long COVID patients display a range of symptoms that expose SARS-CoV-2s versatility and its lasting effect on organ function. While this heterogeneity makes it difficult to study the disease, scientists apply every available technology to investigate the virus pathological systems. In this webinar given you by Cayman Chemical, Floyd Chilton and Thomas Bumol will talk about how they integrate metabolomics, transcriptomics, and immune profiling to study SARS-CoV-2s capability to attack multiple organs, even after the infection has actually been cleared from the body.Topics to be coveredMolecular networks and enzymes that figure out COVID-19 mortalityPersistent inflammatory signatures in long COVIDRegister NowMeet the Speakers: Floyd (Ski) H. Chilton, PhDProfessor, School of Nutritional Sciences and WellnessDirector, Precision Nutrition and Wellness InitiativeThe University of ArizonaThomas F. Bumol, PhDExecutive Vice President and DirectorAllen Institute for Immunology
